General

A scan of hundreds of real-world questions on DrugChatter reveals a consistent pattern: patients are not just asking what a

A growing share of medication questions aren’t being asked in exam rooms. They’re being typed into search bars and forums

Patients are increasingly turning to online forums before their first dose—less for diagnosis, more for reassurance. The result is a

There’s a particular genre of drug question that never goes out of style: “What happens if I mess this up?”

There’s a pattern to mass adoption in pharma. First comes clinical data, then prescriber uptake, then—inevitably—the public internet asking the

There used to be a reliable playbook. You identified the twenty physicians who shaped prescribing behavior in a given therapeutic

Every time ChatGPT answers a drug question, it may be doing something no FDA-approved ad campaign ever could — and

By the time your next drug launches, a chatbot will already have an opinion about it — and 40 million

Why Pharmaceutical Companies Must Monitor AI Mentions Right Now There is a new drug representative calling on your patients and

How pharmaceutical brands are losing control of their narrative to AI answer engines — and the monitoring infrastructure they need

The Question Every Pharma Brand Team Is Ignoring Somewhere right now, a 54-year-old with newly diagnosed Type 2 diabetes is

What pharma’s regulatory, medical affairs, and brand teams need to do right now There is a scenario playing out across